MassDevice

Gore wins FDA nod for deep venous stent

W.L. Gore & Associates announced today that the FDA approved its Viabahn Fortegra venous stent, formerly known as Viafort.
Becker's Hospital Review

FDA approves first venous stent for IVC, iliofemoral use

FDA approves first venous stent for IVC and iliofemoral veins, offering a new treatment for deep venous disease with proven 12-month patency.

GORE GAINS FDA APPROVAL FOR FIRST DEEP VENOUS STENT INDICATED FOR THE IVC AND ILIOFEMORAL VEINS

W. L. Gore & Associates' medical business (Gore) has announced the FDA approval of the GORE® VIABAHN® FORTEGRA Venous Stent — ...
Medical Device and Diagnostic Industry (MD+DI)

Gore Secures New FDA Approval Amidst Endovascular Acquisition

W. L. Gore & Associates has secured FDA approval for the GORE VIABAHN FORTEGRA Venous Stent — previously known as the GORE ...
Yahoo Finance

GORE ANNOUNCES POSITIVE CLINICAL TRIAL RESULTS OF THE INVESTIGATIONAL GORE® VIABAHN® FORTEGRA VENOUS STENT FOR TREATMENT OF PATIENTS WITH DEEP VENOUS ...

The investigational device evaluated in the trial, previously known as the GORE ® VIAFORT Vascular Stent, will now be referred to as the GORE ® VIABAHN ® FORTEGRA Venous Stent. CAUTION: ...
TCTMD

TCT 620: Endovascular Treatment (Stenting) of Total IVC Obstruction With Collaterals in Young Adult With Crohn’s Disease

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
MarketWatch

GORE ANNOUNCES POSITIVE CLINICAL TRIAL RESULTS OF THE INVESTIGATIONAL GORE(R) VIABAHN(R) FORTEGRA VENOUS STENT FOR TREATMENT OF PATIENTS WITH DEEP ...

The MarketWatch News Department was not involved in the creation of this content. The investigational device evaluated in the trial, previously known as the GORE(R) VIAFORT Vascular Stent, will now be ...